Skip to main content
GH $157.21 -1.46%
GH logo

GH · Guardant Health, Inc.

Track GH — free
$157.21 -2.33 (-1.46%) At close · Aug 14
Market Cap
$21.10B
Shares
134.20M
All earnings calls

Earnings call · FY2024 Q1

Guardant Health, Inc. Q1 FY2024 Earnings Call

Guardant Health, Inc. Q1 FY2024 Earnings Call

Concluded May 9, 2024
May 9, 2024 30 turns
Period
FY2024 Q1
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Interest rate environment and rate sensitivity 13 Capital recycling and distribution policy 9 Investment pipeline and new construction LIHTC challenges 6 Freestone and other JV development pipeline 5 Book value decline and fair value adjustments 4 Liquidity and leverage 4

Management tone

Balanced

Net tone +5 · moderate hedging

Grounding quotes
  • “we have had no forbearance requests for multifamily mortgage revenue bonds and all such borrowers are current on their principal and interest payments”
  • “We continue to see no material supply chain or labor disruptions on the Vantage projects under construction”
  • “Our base case uses the forward SOFR yield curve as of March 31, which includes market anticipated SOFR rate declines over the next 12 months”
  • “I think generally it's an overall lower cost that I think will ultimately translate better dynamics for the industry. And I think we'll just have to wait and see that if and when these first rounds of Fed rate cuts happen this year, what the market reaction will be”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $168.49M +30.9% YoY
Diluted EPS -$0.94
Net income -$114.98M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Oncology$125.75M
Biopharma Data$37.59M
Licensing Other$5.16M
Screening$0
Full-screen source Call document